Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders

Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders

On December 18, 2024, a meeting of the Expert Council was held to discuss approaches to the treatment of non-specific back pain and pain in rheumatic musculoskeletal disorders. It was noted that non-steroidal anti-inflammatory drugs (NSAIDs) remain the mainstay of therapy for inflammation-related pa...

Full description

Saved in:
Bibliographic Details
Main Authors: A. M. Lila, V. A. Parfenov, A. E. Karateev, T. V. Adasheva, L. I. Alekseeva, V. V. Afanasyev, E. R. Barantsevich, O. V. Vorobyeva, O. S. Davydov, E. V. Ekusheva, A. I. Zagrebneva, D. A. Iskra, M. L. Kukushkin, A. P. Rachin, E. S. Filatova, M. V. Churyukanov, V. A. Shirokov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2025-02-01
Series:Современная ревматология
Subjects:
back pain
inflammation
rheumatoid arthritis
osteoarthritis
non-steroidal anti-inflammatory drugs
pelubiprofen
efficacy
safety
Online Access:https://mrj.ima-press.net/mrj/article/view/1712
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://mrj.ima-press.net/mrj/article/view/1712

Similar Items